Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioScience Health Innovations (BHIC) Shares Outstanding (Weighted Average) (2019 - 2025)

Historic Shares Outstanding (Weighted Average) for BioScience Health Innovations (BHIC) over the last 7 years, with Q3 2025 value amounting to $11.0 million.

  • BioScience Health Innovations' Shares Outstanding (Weighted Average) rose 482.14% to $11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 482.14%. This contributed to the annual value of $41.9 million for FY2024, which is 2419.48% up from last year.
  • As of Q3 2025, BioScience Health Innovations' Shares Outstanding (Weighted Average) stood at $11.0 million, which was up 482.14% from $43.9 million recorded in Q2 2025.
  • Over the past 5 years, BioScience Health Innovations' Shares Outstanding (Weighted Average) peaked at $43.9 million during Q1 2025, and registered a low of $5.5 million during Q1 2021.
  • In the last 5 years, BioScience Health Innovations' Shares Outstanding (Weighted Average) had a median value of $11.0 million in 2025 and averaged $21.4 million.
  • The largest annual percentage gain for BioScience Health Innovations' Shares Outstanding (Weighted Average) in the last 5 years was 19857.07% (2024), contrasted with its biggest fall of 7405.02% (2024).
  • BioScience Health Innovations' Shares Outstanding (Weighted Average) (Quarter) stood at $5.5 million in 2021, then changed by 0.0% to $5.5 million in 2022, then surged by 518.23% to $33.8 million in 2023, then grew by 24.19% to $41.9 million in 2024, then crashed by 73.82% to $11.0 million in 2025.
  • Its last three reported values are $11.0 million in Q3 2025, $43.9 million for Q2 2025, and $43.9 million during Q1 2025.